✦ LIBER ✦

P-098 p53 protein expression predicts outcome and cytogenetic response in patients with low-/INT-1-risk myelodysplastic syndromes treated with lenalidomide

✍ Scribed by Saft, L.; Karimi, M.; Ghaderi, M.; Matolscy, A.; Fenaux, P.; Mufti, G.; Giagounidis, A.; Selleslag, D.; Muus, P.; Sanz, G.; Mittelman, M.; Bowen, D.; Porwit, A.; Fu, T.; Backstrom, J.; MacBeth, K.; Hellström-Lindberg, E.

Book ID: 123296378
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 269 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/S0145-2126(13)70146-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor suppressor p53 protein expression:

Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome

✍ Duarte, Fernando Barroso; Gonçalves, Romelia Pinheiro; Barbosa, Maritza Cavalcan 📂 Article 📅 2014 🏛 SciELO 🌐 English ⚖ 833 KB

Scientific comment on tumor suppressor p

Scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome

✍ Velloso, Elvira Deolinda Rodrigues Pereira 📂 Article 📅 2014 🏛 SciELO 🌐 English ⚖ 524 KB

P-104 Outcomes by IPSS-R in lenalidomide

P-104 Outcomes by IPSS-R in lenalidomide-treated patients with IPSS low-/Int-1-risk MDS With del(5q) in MDS-003 and MDS-004: A retrospective analysis

✍ Sekeres, M.; Swern, A.; Fenaux, P.; Greenberg, P.; Sanz, G.; Bennett, J.; Dreyfu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Low p53 Binding Protein 1 (53BP1) Expres

Low p53 Binding Protein 1 (53BP1) Expression Is Associated With Increased Local Recurrence in Breast Cancer Patients Treated With Breast-Conserving Surgery and Radiotherapy

✍ Hanmanth J.R. Neboori; Bruce G. Haffty; Hao Wu; Qifeng Yang; Amal Aly; Sharad Go 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 730 KB